Ticagrelor is a platelet aggregation inhibitor. It is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation.

The global Ticagrelor market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ticagrelor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ticagrelor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Astrazeneca
Pfizer
Bayer
Johnson & Johnson
Merck
Boehringer Ingelheim
Eli Lilly
Sun Pharmaceutical

Segment by Regions
North America
Europe
China
Japan

Segment by Type
90 mg Tablet
60 mg Tablet

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies